# Single cell RNA-sequencing identified CCR7+/RELB+/IRF1+ T cell responding for juvenile idiopathic arthritis pathogenesis

**Authors:** Lewei He, Xue Gong, Hui Guo, Kaiyu Zhou, Yue Lan, Mingyi Lv, Xiaoliang Liu, Sha Lin, Yimin Hua, Junling Guo, Zhenxin Fan, Yifei Li

PMC · DOI: 10.3389/fimmu.2025.1528446 · Frontiers in Immunology · 2025-05-08

## TL;DR

This study uses single-cell RNA sequencing to identify a specific type of T cell linked to juvenile idiopathic arthritis, especially in patients with HLA-B27.

## Contribution

The discovery of CCR7+/RELB+/IRF1+ T cells as a key player in JIA pathogenesis, particularly in HLA-B27+ patients, is novel.

## Key findings

- CCR7+/RELB+/IRF1+ T cells are more prevalent in JIA patients, especially those with HLA-B27.
- These T cells produce IL-17, which may contribute to cartilage damage in HLA-B27+ JIA patients.
- Such T cells are not found in pSS or SLE patients and produce less IL-17 compared to JIA patients.

## Abstract

To further explore the disease heterogeneity of different subtypes of Juvenile idiopathic arthritis (JIA) and analyze their pathogenesis mechanisms.

The single-cell RNA sequencing (scRNA-seq) analysis of peripheral blood mononuclear cells (PBMCs) was carried out to investigate the disease heterogeneity and molecular mechanisms of immune responses in immune cells in JIA.

In our study, we provided a immunological landscape of HLA-B27-positive JIA and HLA-B27-negative JIA immune cells at single cell RNA-Seq resolution. We found a higher proportion of CCR7+/RELB+/IRF1+ triple positive T cells in the peripheral blood of patients with JIA, and such T cells were predominantly present in HLA-B27+ JIA patients. Furthermore, we hypothesized that CCR7+/RELB+/IRF1+ triple positive T cells were highly activated T cells capable of promoting the differentiation of osteoclasts by producing IL-17, thus causing damage to cartilage in HLA-B27+ JIA patients. Unlike JIA patients, CCR7+/RELB+/IRF1+ triple positive T cells were not found in the peripheral blood of pSS patients and SLE patients, moreover, T cells from pSS patients and SLE patients were less able to produce IL-17 than those from JIA patients.

Our study provided evidence of cellular and molecular levels of involvement in JIA pathogenesis and identified the critical roles for T cells in JIA pathogenesis. Furthermore, our results suggested that there were significant differences in T cell composition and gene expression between HLA-B27+ JIA patients and HLA-B27- JIA patients. Our findings indicated that CCR7+/RELB+/IRF1+ positive T cells could damage the cartilage of HLA-B27+ JIA by producing cytokines such as IL-17.

## Linked entities

- **Genes:** CCR7 (C-C motif chemokine receptor 7) [NCBI Gene 1236], RELB (RELB proto-oncogene, NF-kB subunit) [NCBI Gene 5971], IRF1 (interferon regulatory factor 1) [NCBI Gene 3659]
- **Proteins:** IL17A (interleukin 17A)
- **Diseases:** juvenile idiopathic arthritis (MONDO:0011429), pSS (MONDO:0011022), SLE (MONDO:0007915)

## Full-text entities

- **Genes:** RELB (RELB proto-oncogene, NF-kB subunit) [NCBI Gene 5971] {aka I-REL, IMD53, IREL, REL-B}, CCR7 (C-C motif chemokine receptor 7) [NCBI Gene 1236] {aka BLR2, CC-CKR-7, CCR-7, CD197, CDw197, CMKBR7}, HLA-B (major histocompatibility complex, class I, B) [NCBI Gene 3106] {aka AS, B-4901, HLAB}, IL17A (interleukin 17A) [NCBI Gene 3605] {aka CTLA-8, CTLA8, IL-17, IL-17A, IL17, ILA17}, IRF1 (interferon regulatory factor 1) [NCBI Gene 3659] {aka IMD117, IRF-1, MAR}
- **Diseases:** cartilage (MESH:D002357), SLE (MESH:D008180), JIA (MESH:D001171)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12095314/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12095314/full.md

## References

60 references — full list in the complete paper: https://tomesphere.com/paper/PMC12095314/full.md

---
Source: https://tomesphere.com/paper/PMC12095314